Cargando…
Novel strategies to target chemoresistant triple-negative breast cancer
Previous studies from our group and others have shown that current drug treatment(s) strategies eliminate bulk of tumor cells (non-CSCs) but it had a minimal effect on cancer stem cells (CSCs) leading to resistance and tumor recurrence. We studied the effects of CFM-4.16 (CARP-1 functional mimetic)...
Autores principales: | Venkatesh, Jaganathan, Rishi, Arun K., Reddy, Kaladhar B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805540/ https://www.ncbi.nlm.nih.gov/pubmed/33488948 http://dx.doi.org/10.18632/genesandcancer.204 |
Ejemplares similares
-
Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells
por: Yin, Shuping, et al.
Publicado: (2017) -
Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer
por: Bousquet, Guilhem, et al.
Publicado: (2017) -
High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target
por: Bousquet, Guilhem, et al.
Publicado: (2019) -
The fate of chemoresistance in triple negative breast cancer (TNBC)
por: O’Reilly, Elma A., et al.
Publicado: (2015) -
Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies
por: Chakrabarty, Anindita, et al.
Publicado: (2021)